Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8;10(1):136.
doi: 10.1186/s40478-022-01439-z.

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

Affiliations

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

Haoshen Shi et al. Acta Neuropathol Commun. .

Abstract

Single cell RNA sequencing studies identified novel neurodegeneration-associated microglial (MGnD/DAM) subtypes activated around cerebral amyloid plaques. Micro-RNA (miR)-155 of the TREM2-APOE pathway was shown to be a key transcriptional regulator of MGnD microglial phenotype. Despite growing interest in studying manifestations of Alzheimer's disease (AD) in the retina, a CNS organ accessible to noninvasive high-resolution imaging, to date MGnD microglia have not been studied in the AD retina. Here, we discovered the presence and increased populations of Clec7a+ and Galectin-3+ MGnD microglia in retinas of transgenic APPSWE/PS1L166P AD-model mice. Conditionally targeting MGnD microglia by miR-155 ablation via the tamoxifen-inducible CreERT2 system in APPSWE/PS1L166P mice diminished retinal Clec7a+ and Galectin-3+ microglial populations while increasing homeostatic P2ry12+ microglia. Retinal MGnD microglia were often adhering to microvessels; their depletion protected the inner blood-retina barrier and reduced vascular amyloidosis. Microglial miR-155 depletion further limits retinal inflammation. Mass spectrometry analysis revealed enhanced retinal PI3K-Akt signaling and predicted IL-8 and Spp1 decreases in mice with microglia-specific miR-155 knockout. Overall, this study identified MGnD microglia in APPSWE/PS1L166P mouse retina. Transcriptional regulation of these dysfunctional microglia mitigated retinal inflammation and vasculopathy. The protective effects of microglial miR-155 ablation should shed light on potential treatments for retinal inflammation and vascular damage during AD and other ocular diseases.

Keywords: Alzheimer’s disease; Inflammation; Microglia; Retinopathy; Vascular damage; microRNA.

PubMed Disclaimer

Conflict of interest statement

O.B. is an inventor of a patent for use miR-155 inhibitors in neurodegenerative diseases. O.B. and M.A.M. are co-inventors of a patent for use of Galectin-3 inhibitors for treatment of glaucoma. O.B.: collaboration with Sanofi, GSK, Regulus Therapeutics; research funding from Sanofi, GSK, miRagen Therapeutics, honoraria for lectures, consultancy: Camp4.

Figures

Fig. 1
Fig. 1
Targeting microglial miR-155 diminished the population of Clec7a+ MGnD microglia. a Schema for generation of wild type (WT) and Alzheimer’s disease (AD) mice that were specifically targeted for miR-155 in microglia. miR-155 fl/fl:APP/PS1 mice and miR-155 fl/fl:Cx3cr1CreERT2 mice were crossed to create APP/PS1:miR155cKO mice. Other experimental groups include APP/PS1, WT:miR155cKO and WT. Two consecutive doses of tamoxifen (150 mg/kg) were introduced peritoneally to 1.5-month-old mice to induce conditional microglial miR-155 knock-out. Mice were sacrificed at 4 months or 8 months for cross-section, vascular isolation, flat mount, mass spectrometry (MS), western blotting (WB) and Meso Scale Discovery (MSD). This illustration was created by using Biorender.com. be Representative images of immunofluorescent staining for Clec7a+ microglia (red), Tmem119+ microglia (green) and lectin for blood vessels (blue) on retinal flat mounts from b APP/PS1 genotype, ganglion cell layer (GCL) to inner plexiform layer (IPL); c APP/PS1 genotype, outer plexiform layer (OPL); d WT genotype, GCL to IPL; and e APP/PS1:miR155cKO genotype, GCL to IPL. Images were obtained using 20 × microscope objectives. Arrows indicate Clec7a+ microglia. Scale bars = 10 µm. f Manual counting of Clec7a+ microglia in each entire retinal cross-section from all experimental groups (n = 48 total, n = 6 each group). g Ratio of Clec7a+ microglia to Iba1+ microglia from the same mouse cohort. Data from individual mice (circles) as well as group means ± SEMs are shown. Black-filled circles represent male and clear circles represent female animals. *p < 0.05, **p < 0.01, ***p < 0.001, by three-way ANOVA with Tukey’s post-hoc multiple comparison test. Two group statistical analysis was performed using an unpaired two-tailed Student t-test and is shown in parentheses. Fold changes and percentage decreases are shown in red
Fig. 2
Fig. 2
Conditional depletion of microglial miR-155 decreases Galectin-3+ microglia and upregulates homeostatic P2ry12 expression in APP/PS1 mice retinas. ae Representative images of immunofluorescent staining for Galectin-3+ microglia (red), Tmem119+ microglia (green) and lectin for blood vessels (blue) on retinal flat mounts from a APP/PS1:miR-155cKO genotype, inner plexiform layer (IPL); b APP/PS1 genotype, ganglion cell layer (GCL) to IPL; c APP/PS1 genotype, outer plexiform layer (OPL); d APP/PS1:miR-155cKO genotype, IPL; and e APP/PS1 genotype, IPL. Images were obtained using 20 × or 63 × microscope objectives. Dashed-line rectangles highlight Galectin-3+ microglia. Scale bars = 10 µm. f Quantitative analysis of 12F4 for Aβ42 immunoreactivity (IR) in retinal cross-sections of mice from all experimental groups (n = 48 total, n = 6 each group). g Manual counting of Galectin-3+ microglia in each retinal cross-section from all experimental groups of the same mouse cohort. h Representative images of immunofluorescent staining for Galectin-3+ microglia (red), Iba1+ microglia (green), 12F4 for Aβ42 (white) and DAPI (blue) on retinal cross-sections from APP/PS1:miR-155cKO and APP/PS1 mice. Images were obtained using 40 × microscope objectives. Dashed-line rectangle highlights a Galectin-3+ microglia engulfing Aβ42. Scale bars = 10 µm. i, j. Representative images of eye cross-section depicting immunofluorescent staining for i Tmem119+ microglia (red), 12F4 for Aβ42 (green) and DAPI (blue) from an APP/PS1:miR-155cKO mouse and j P2ry12+ microglia (red), 12F4 for Aβ42 (green) and DAPI (blue) from an APP/PS1 mouse. k Manual counting of Tmem119+ microglia in each retinal cross-section from all experimental groups of the same mouse cohort. l Densitometric analysis of western blotting protein bands of P2ry12 normalized by β-actin control for retinal lysates from all experimental groups (n = 48 total, n = 6 each group). m Manual counting of Apoe+ microglia in each retinal cross-section from all experimental groups of the same mouse cohort shown in figures g and k n Densitometric analysis of western blotting protein bands of Iba1 normalized by β-actin control for retinal lysates from all experimental groups of the same cohort as figure l. Data from individual mice (circles) as well as group means ± SEMs are shown. Black-filled circles represent male and clear circles represent female animals. *p < 0.05, **p < 0.01, by two-way or three-way ANOVA with Tukey’s post-hoc multiple comparison test. Two group statistical analysis was performed using an unpaired two-tailed Student t-test and is shown in parentheses. Fold changes and percentage decreases are shown in red
Fig. 3
Fig. 3
Targeting microglial miR-155 ameliorates inflammation in APP/PS1 mouse retinas. ac Densitometric analyses of western blotting protein bands of a phosphorylated NF-κB p65, b mature IL-1β, and c. TNF-α normalized by a total NF-κB p65 or b and c β-actin control for retinal lysates from all experimental groups (n = 48 total, n = 6 each group). di Meso Scale Discovery analysis for protein expression of cytokines including d IL-2, e IL-5, f IL-12, g IFN-γ, h IL-6 and i IL-10 from the same mouse cohort. Data from individual mice (circles) as well as group means ± SEMs are shown. Black-filled circles represent male and clear circles represent female animals. *p < 0.05, **p < 0.01, by three-way ANOVA with Tukey’s post-hoc multiple comparison test. Two group statistical analysis was performed using an unpaired two-tailed Student t-test and is shown in parentheses. Fold changes and percentage decreases are shown in red
Fig. 4
Fig. 4
Conditional microglial miR-155 knock-out enhanced PI3K-Akt signaling in APP/PS1 mouse retinas. a Detectable protein hierarchies displayed as heatmaps from a a comparison of 8-month-old WT and WT:miR-155cKO mice and b a comparison of 8-month-old APP/PS1 and APP/PS1:miR-155cKO mice; upregulated proteins are shown in purple and downregulated proteins in green. c, d Principal component analysis for a and b ef Volcano plots and top 15 up- or downregulated proteins by fold change between e 8-month-old WT vs. WT:miR-155cKO mice and f 8-month-old APP/PS1 vs. APP/PS1:miR-155cKO mice; upregulated proteins are shown in purple and downregulated proteins in green. g Pie chart of PANTHER functional classification analysis showing fraction and percentage of significantly differentially expressed proteins (DEPs, up- or downregulated proteins) grouped by protein class category based on a comparison of APP/PS1 and APP/PS1:miR-155cKO mice. h Ingenuity pathway analysis (IPA) of canonical pathways based on APP/PS1 vs. APP/PS1:miR-155cKO mice. Several upregulated PI3K-Akt pathways are shown here. P values are labelled on each pathway. Quantities of commonly changed molecules between each two pathways are labelled in red together with highlighted molecules and detectable fold changes. i Z-scores for the IPA analysis of canonical pathways from 8-month-old WT vs. WT:miR-155cKO mice and 8-month-old APP/PS1 and APP/PS1:miR-155cKO mice. jl Densitometric analysis of western blotting protein bands of j EIF3c, k NDUFA10, and l NDUFA6, each normalized by β-actin control for retinal lysates from all experimental groups (n = 48 total, n = 6 each group). m IPA analysis for upstream regulators Spp1 and Cxcl-8 based on 8-month-old APP/PS1 vs. APP/PS1:miR-155cKO versus mice. Refer to “prediction legend” in the graph for details. Detectable fold changes of DEPs are written next to each molecule. CP-common pathways. n Densitometric analysis of western blotting protein bands of SPP1 normalized by β-actin control for retinal lysates from the same cohort. Data from individual mice (circles) as well as group means ± SEMs are shown. Black-filled circles represent male and clear circles represent female animals. *p < 0.05, **p < 0.01, by three-way ANOVA with Tukey’s post-hoc multiple comparison test. Two group statistical analysis was performed using an unpaired two-tailed Student t-test and is shown in parentheses. Fold changes and percentage decreases are shown in red
Fig. 5
Fig. 5
Targeting microglial miR-155 protected retinal blood vessels and reduced vascular amyloidosis in APP/PS1 mouse retinas. a Representative images of immunofluorescent staining for 4G8 of Aβ (magenta), Claudin-1 (red), lectin for blood vessels (green) and DAPI (blue) on isolated retinal blood vessels from all four genotypes—WT, WT:miR-155cKO, APP/PS1, and APP/PS1:miR-155cKO—in 8-month-old mice. Images were obtained using the 63 × microscope objective. Arrows indicate vascular Aβ. Scale bars = 10 µm. b Quantitative analysis of Claudin-1-immunoreactivity (IR) in isolated retinal blood vessels from all 8-month-old experimental groups (n = 24 total, n = 6 each group). c Densitometric analysis of western blotting protein bands of Claudin-1 normalized by β-actin control for retinal lysates from all experimental groups (n = 48 total, n = 6 each group). d Representative images of immunofluorescent staining for 11A50-B10 of Aβ40 (magenta), ZO-1 (red), lectin for blood vessels (green) and DAPI (blue) on isolated retinal blood vessels from all four genotypes—WT, WT:miR-155cKO, APP/PS1, and APP/PS1:miR-155cKO—in 8-month-old mice. Images were obtained using the 63 × microscope objective. Arrows indicate vascular Aβ. Scale bars = 10 µm. e Quantitative analysis of ZO-1-IR in isolated retinal blood vessels from same mouse cohort as shown in panel b. f Quantitative analysis of 11A50-B10 for Aβ40-IR in isolated retinal blood vessels from 8-month-old APP/PS1 experimental groups (n = 12 total, n = 6 each group). g Representative images of immunofluorescent staining of 4G8 for Aβ (magenta) on isolated retinal blood vessels from 8-month-old APP/PS1 or APP/PS1:miR-155cKO mice groups. h Quantitative analysis of 4G8 for Aβ in isolated retinal blood vessels from the same mouse cohort shown in panel f. i Densitometric analysis of western blotting protein bands of MMP-9 normalized by β-actin control for retinal lysates from APP/PS1:miR-155cKO vs. APP/PS1 mice (n = 12 total, n = 6 each group). j, k Pearson’s coefficient (r) correlation between j. retinal vascular Aβ40 and retinal Clec7a+ microglia, k retinal vascular Claudin-1-IR and retinal Clec7a+ microglia or retinal vascular Aβ-IR. Data from individual mice (circles) as well as group means ± SEMs are shown. Black-filled circles represent male and clear circles represent female animals. *p < 0.05, **p < 0.01, by two-way or three-way ANOVA with Tukey’s post-hoc multiple comparison test. Two group statistical analysis was performed using an unpaired two-tailed Student t-test. Fold changes and percentage decreases are shown in red

References

    1. Al-Huseini I, Harada M, Nishi K, Nguyen-Tien D, Kimura T, Ashida N. Improvement of insulin signalling rescues inflammatory cardiac dysfunction. Sci Rep. 2019;9:14801. doi: 10.1038/s41598-019-51304-8. - DOI - PMC - PubMed
    1. Antes R, Salomon-Zimri S, Beck SC, Garcia Garrido M, Livnat T, Maharshak I, Kadar T, Seeliger M, Weinberger D, Michaelson DM. VEGF Mediates ApoE4-Induced neovascularization and synaptic pathology in the choroid and retina. Curr Alzheimer Res. 2015;12:323–334. doi: 10.2174/1567205012666150325182504. - DOI - PubMed
    1. Asanad S, Ross-Cisneros FN, Nassisi M, Barron E, Karanjia R, Sadun AA. The retina in Alzheimer's disease: histomorphometric analysis of an ophthalmologic biomarker. Invest Ophthalmol Vis Sci. 2019;60:1491–1500. doi: 10.1167/iovs.18-25966. - DOI - PMC - PubMed
    1. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59:2872–2882. doi: 10.2337/db09-1606. - DOI - PMC - PubMed
    1. Bachiller S, Jimenez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A. Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front Cell Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488. - DOI - PMC - PubMed

Publication types